Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Dec 30, 2021 10:28pm
221 Views
Post# 34272902

RE:RE:RE:RE:RE:Science discussion - for TLT geeks only

RE:RE:RE:RE:RE:Science discussion - for TLT geeks only

From the press releases it sounds like PR patients have not yet had CT scans? Are they waiting till end of trial?  Would be good to find out.  


socksnblonds642 wrote: All good thoughts I think. I read your post as a positive outlook on long term correct dose PR's. It's not a stretch to consider that CT's have been performed. From what I understand you are speculating that a good PR is better than a NR. It's also healthy to pump the brakes once in a while, so easy to get caught up in the positive results. We are all waiting to see what happens to these partial responses. Back flips if the all become CR's of course..I hadn't considered that they could stay a PR. 

 

<< Previous
Bullboard Posts
Next >>